DBV Technologies is the pioneer of an exciting non-invasive epicutaneous delivery system that offers unique advantages for a wide range of diagnostic and medical treatments. Based on its proprietary VIASKIN^® technology, DBV Technologies is currently focused on the development of epicutaneous delivery systems for allergy diagnostics, allergy desensitisation therapy, vaccine administration and cosmaceuticals.